Novavax Inc (NVAX)
4.145
-0.04
(-1.07%)
USD |
NASDAQ |
Apr 24, 15:59
Novavax Gross Profit Margin (Quarterly): 38.84% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 38.84% |
| September 30, 2023 | -348.4% |
| June 30, 2023 | 86.86% |
| March 31, 2023 | |
| December 31, 2022 | 36.85% |
| September 30, 2022 | 30.83% |
| June 30, 2022 | -45.80% |
| March 31, 2022 | 97.49% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | 50.97% |
| June 30, 2014 | 38.22% |
| March 31, 2014 | 59.51% |
| December 31, 2013 | |
| September 30, 2013 | 52.60% |
| June 30, 2013 | 53.78% |
| March 31, 2013 | 55.34% |
| December 31, 2012 | 57.25% |
| September 30, 2012 | 33.43% |
| June 30, 2012 | 27.95% |
| March 31, 2012 | 18.44% |
| December 31, 2011 | 44.57% |
| September 30, 2011 | 56.27% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-348.4%
Minimum
Sep 2023
97.49%
Maximum
Mar 2022
-14.76%
Average
36.85%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 46.92% |
| Moderna Inc | 66.97% |
| Agilent Technologies Inc | 54.76% |
| Lexicon Pharmaceuticals Inc | 90.03% |
| Vaxart Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -30.48% |
| Profit Margin (Quarterly) | -70.40% |
| Operating Margin (Quarterly) | -72.44% |
| Return on Net Operating Assets | -63.77% |